{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2007"],"condition":["Ovarian Cancer","Bowel Obstruction","Fallopian Tube Neoplasms","Fallopian Tube Cancer","Peritoneal Cavity Cancer","Constipation","Intestinal Obstruction"],"disease":["Ovarian Cancer","Bowel Obstruction","Fallopian Tube Neoplasms","Fallopian Tube Cancer","Peritoneal Cavity Cancer","Constipation","Intestinal Obstruction"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2044746"],"location":["United States"],"study_start_month":["4"],"keyword":["Constipation, impaction, and bowel obstruction","Ovarian epithelial cancer"],"repository":["ECRIN MDR"],"study_status":["Terminated"],"additional_accession":[]},"is_claimable":false,"name":"Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","description":"RATIONALE: Gathering information about changes in serotonin levels in patients undergoing chemotherapy for ovarian cancer, fallopian tube cancer, or primary peritoneal cancer may help doctors learn more about constipation caused by chemotherapy.\nPURPOSE: This clinical trial is studying how blood levels of serotonin effect constipation caused by chemotherapy in patients with newly diagnosed ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.","dates":{"creation":"2007-04-15"},"accession":"2044746","cross_references":{"ClinicalTrials___gov":["NCT00536523"]}}